Key result
Biallelic variants of ADSSL1 in 63 Japanese patients caused variable symptoms including dysphagia (26 of 63), hypertrophic cardiomyopathy (12 of 48), and ventilatory insufficiency (26 of 34).
Why the study?
To elucidate the prevalence of Japanese ADSSL1 myopathy and determine the clinicopathologic features of the disease.
Observational (n=63)
No
ADSSL1 myopathy is the most common genetically diagnosable nemaline myopathy in Japan, presenting with variable muscle symptoms and frequently complicated by hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
ADSSL1 myopathy may warrant targeted testing in Japanese myopathy patients; leaves open global prevalence and natural history studies.
Objective To elucidate the prevalence of Japanese ADSSL1 myopathy and determine the clinicopathologic features of the disease. Methods We searched for ADSSL1 variants in myopathic patients from January 1978 to March 2019 in our repository and assessed the clinicopathologic features of patients with variants. Results We identified 63 patients from 59 families with biallelic variants of ADSSL1. Among the 7 distinct variants identified, c.781G>A and c.919delA accounted for 53.2% and 40.5% of alleles, respectively, suggesting the presence of common founders, while the other 5 were novel. Most of the identified patients displayed more variable muscle symptoms, including symptoms in the proximal and/or distal leg muscles, tongue, masseter, diaphragm, and paraspinal muscles, in adolescence than previously reported patients. Dysphagia with masticatory dysfunction developed in 26 out of 63 patients; hypertrophic cardiomyopathy developed in 12 out of 48 patients; and restrictive ventilatory insufficiency developed in 26 out of 34 patients in later stages. Radiologically, fat infiltration into the periphery of vastus lateralis, gastrocnemius, and soleus muscles was observed in all patients. Pathologically, nemaline bodies in addition to increased lipid droplets and myofibrillar disorganization were commonly observed in all patients, suggesting that the disease may be classified as nemaline myopathy. This finding revealed that ADSSL1 myopathy is the most frequent among all genetically diagnosable nemaline myopathies in our center. Conclusions ADSSL1 myopathy is characterized by more variable manifestations than previously reported. It is the most common among all genetically diagnosable nemaline myopathies in our center, although mildly increased lipid droplets are also constantly observed features.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2020) conducted an observational in ADSSL1 myopathy (n=63). Biallelic variants of ADSSL1 was evaluated on Clinicopathologic features and prevalence. Biallelic variants of ADSSL1 in 63 Japanese patients caused variable symptoms including dysphagia (26 of 63), hypertrophic cardiomyopathy (12 of 48), and ventilatory insufficiency (26 of 34).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: